Gynae BT 2017
Take home messages
Elective lymph node target: 45-50Gy EBRT Perspective of reducing morbidity with 45Gy Pathological lymph nodes: 55-60Gy EBRT Balance between tumour control and morbidity Primary tumour (CTV HR ): With more IC/IS BT it is possible to reduce EBRT dose to 45Gy Overall treatment time: <50 days >85-90Gy EBRT+BT Balance between EBRT and BT
17
Made with FlippingBook - Online catalogs